CD74 is a potential biomarker predicting the response to immune checkpoint blockade
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
CD74 is a potential biomarker predicting the response to immune checkpoint blockade ; volume:24 ; number:1 ; day:14 ; month:10 ; year:2024 ; pages:1-13 ; date:12.2024
Cancer cell international ; 24, Heft 1 (14.10.2024), 1-13, 12.2024
- Urheber
-
Shi, Wen-Qi
Chen, Dan-Xun
Du, Ze-Sen
Liu, Chun-Peng
Zhai, Tian-Tian
Pan, Feng
Chen, Hai-Lu
Liao, Wei-Nan
Wang, Shao-Hong
Fu, Jun-Hui
Qiu, Si-Qi
Wu, Zhi-Yong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-024-03524-w
- URN
-
urn:nbn:de:101:1-2501012115305.871530349704
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shi, Wen-Qi
- Chen, Dan-Xun
- Du, Ze-Sen
- Liu, Chun-Peng
- Zhai, Tian-Tian
- Pan, Feng
- Chen, Hai-Lu
- Liao, Wei-Nan
- Wang, Shao-Hong
- Fu, Jun-Hui
- Qiu, Si-Qi
- Wu, Zhi-Yong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Activation of phagocytosis by immune checkpoint blockade
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
Prospects for combining immune checkpoint blockade with PARP inhibition
The role of neoantigen in immune checkpoint blockade therapy
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Activation of phagocytosis by immune checkpoint blockade
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
Prospects for combining immune checkpoint blockade with PARP inhibition
The role of neoantigen in immune checkpoint blockade therapy
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Regulatory T cells in immune checkpoint blockade antitumor therapy
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Gut microbiome for predicting immune checkpoint blockade-associated adverse events
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Activation of phagocytosis by immune checkpoint blockade
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
Prospects for combining immune checkpoint blockade with PARP inhibition
The role of neoantigen in immune checkpoint blockade therapy
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Regulatory T cells in immune checkpoint blockade antitumor therapy